Steven Corsello, M.D.
Founder of the Drug Repurposing Hub
Steven Corsello is the founder of the Drug Repurposing Hub at the Broad Institute and an attending physician at the Dana-Farber Cancer Institute. As a member of Todd Golub’s laboratory, Corsello applies new cellular technologies to cancer therapeutic discovery. He currently leads an effort to evaluate all available clinical drugs using information-rich cellular assays and to develop new cancer treatments. As a key contributor to the Connectivity Map project, he also develops translational applications for perturbational gene expression profiling.
Corsello holds an A.B. in biochemical sciences from Harvard College and an M.D. from Harvard Medical School, where he developed gene expression-based screening approaches for leukemia. He completed residency training in internal medicine at Massachusetts General Hospital and a combined fellowship program in hematology and medical oncology at the Dana-Farber Cancer Institute.